Advertisement
111, Inc.

111, Inc. Fundamental Analysis

YINASDAQ
HealthcareMedical - Pharmaceuticals
$4.51
$0.11(2.50%)
U.S. Market opens in 17h 9m
Advertisement

111, Inc. Fundamental Analysis

111, Inc. (YI) shows moderate financial fundamentals with a PE ratio of -3.65, profit margin of -0.66%, and ROE of 13.93%. The company generates $11.2B in annual revenue with weak year-over-year growth of -15.19%.

Key Strengths

Cash Position176.80%
PEG Ratio0.02

Areas of Concern

Operating Margin-0.24%
We analyze YI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 25.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
25.4/100

We analyze YI's fundamental strength across five key dimensions:

Efficiency Score

Weak

YI struggles to generate sufficient returns from assets.

ROA > 10%
-26.90%

Valuation Score

Excellent

YI trades at attractive valuation levels.

PE < 25
-3.65
PEG Ratio < 2
0.02

Growth Score

Weak

YI faces weak or negative growth trends.

Revenue Growth > 5%
-15.19%
EPS Growth > 10%
1.33%

Financial Health Score

Excellent

YI maintains a strong and stable balance sheet.

Debt/Equity < 1
-0.38
Current Ratio > 1
1.08

Profitability Score

Weak

YI struggles to sustain strong margins.

ROE > 15%
13.93%
Net Margin ≥ 15%
-0.66%
Positive Free Cash Flow
No

Key Financial Metrics

Is YI Expensive or Cheap?

P/E Ratio

YI trades at -3.65 times earnings. This suggests potential undervaluation.

-3.65

PEG Ratio

When adjusting for growth, YI's PEG of 0.02 indicates potential undervaluation.

0.02

Price to Book

The market values 111, Inc. at -2.57 times its book value. This may indicate undervaluation.

-2.57

EV/EBITDA

Enterprise value stands at -15.59 times EBITDA. This is generally considered low.

-15.59

How Well Does YI Make Money?

Net Profit Margin

For every $100 in sales, 111, Inc. keeps $-0.66 as profit after all expenses.

-0.66%

Operating Margin

Core operations generate -0.24 in profit for every $100 in revenue, before interest and taxes.

-0.24%

ROE

Management delivers $13.93 in profit for every $100 of shareholder equity.

13.93%

ROA

111, Inc. generates $-26.90 in profit for every $100 in assets, demonstrating efficient asset deployment.

-26.90%

Following the Money - Real Cash Generation

Operating Cash Flow

111, Inc. generates limited operating cash flow of $2.61M, signaling weaker underlying cash strength.

$2.61M

Free Cash Flow

111, Inc. generates weak or negative free cash flow of $-12.42M, restricting financial flexibility.

$-12.42M

FCF Per Share

Each share generates $-1.43 in free cash annually.

$-1.43

FCF Yield

YI converts -4.79% of its market value into free cash.

-4.79%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.65

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2.57

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.02

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.38

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.08

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.14

vs 25 benchmark

ROA

Return on assets percentage

-0.27

vs 25 benchmark

ROCE

Return on capital employed

-0.85

vs 25 benchmark

How YI Stacks Against Its Sector Peers

MetricYI ValueSector AveragePerformance
P/E Ratio-3.6529.34 Better (Cheaper)
ROE13.93%688.00% Weak
Net Margin-0.66%-52372.00% (disorted) Weak
Debt/Equity-0.380.49 Strong (Low Leverage)
Current Ratio1.084.37 Neutral
ROA-26.90%-20476.00% (disorted) Weak

YI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews 111, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

40.99%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

96.51%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

196.61%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ